These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 15215126

  • 1. Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.
    Jacquard AC, Nassal M, Pichoud C, Ren S, Schultz U, Guerret S, Chevallier M, Werle B, Peyrol S, Jamard C, Rimsky LT, Trepo C, Zoulim F.
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2683-92. PubMed ID: 15215126
    [Abstract] [Full Text] [Related]

  • 2. Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus.
    Zhu Y, Cullen JM, Aldrich CE, Saputelli J, Miller D, Seeger C, Mason WS, Jilbert AR.
    Virology; 2004 Sep 15; 327(1):26-40. PubMed ID: 15327895
    [Abstract] [Full Text] [Related]

  • 3. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF, Cote PJ, Jacob JR, Toshkov IA, Hornbuckle WE, Baldwin BH, Wells FV, Chu CK, Gerin JL, Tennant BC, Korba BE.
    Hepatology; 2001 Jan 15; 33(1):254-66. PubMed ID: 11124844
    [Abstract] [Full Text] [Related]

  • 4. Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S, Butler SD, George AL, Tochkov IA, Zhu Y, Xiong S, Gerin JL, Cote PJ, Tennant BC.
    Antimicrob Agents Chemother; 2008 Oct 15; 52(10):3617-32. PubMed ID: 18676881
    [Abstract] [Full Text] [Related]

  • 5. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S, Roneker CA, Tennant BC, Korba BE, Gerin JL, Cote PJ.
    Intervirology; 2002 Oct 15; 45(4-6):237-50. PubMed ID: 12566706
    [Abstract] [Full Text] [Related]

  • 6. Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo.
    Fiedler M, Rödicker F, Salucci V, Lu M, Aurisicchio L, Dahmen U, Jun L, Dirsch O, Pützer BM, Palombo F, Roggendorf M.
    J Virol; 2004 Sep 15; 78(18):10111-21. PubMed ID: 15331744
    [Abstract] [Full Text] [Related]

  • 7. Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.
    Seignères B, Martin P, Werle B, Schorr O, Jamard C, Rimsky L, Trépo C, Zoulim F.
    Antimicrob Agents Chemother; 2003 Jun 15; 47(6):1842-52. PubMed ID: 12760857
    [Abstract] [Full Text] [Related]

  • 8. Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S, Roneker CA, Korba BE, Gerin JL, Tennant BC, Cote PJ.
    J Virol; 2002 Jun 15; 76(11):5305-14. PubMed ID: 11991959
    [Abstract] [Full Text] [Related]

  • 9. Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks.
    Korba BE, Schinazi RF, Cote P, Tennant BC, Gerin JL.
    Antimicrob Agents Chemother; 2000 Jun 15; 44(6):1757-60. PubMed ID: 10817750
    [Abstract] [Full Text] [Related]

  • 10. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection.
    Tennant BC, Baldwin BH, Graham LA, Ascenzi MA, Hornbuckle WE, Rowland PH, Tochkov IA, Yeager AE, Erb HN, Colacino JM, Lopez C, Engelhardt JA, Bowsher RR, Richardson FC, Lewis W, Cote PJ, Korba BE, Gerin JL.
    Hepatology; 1998 Jul 15; 28(1):179-91. PubMed ID: 9657111
    [Abstract] [Full Text] [Related]

  • 11. Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection.
    Korba BE, Cote PJ, Menne S, Toshkov I, Baldwin BH, Wells FV, Tennant BC, Gerin JL.
    Antivir Ther; 2004 Dec 15; 9(6):937-52. PubMed ID: 15651753
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.
    Zhou T, Guo JT, Nunes FA, Molnar-Kimber KL, Wilson JM, Aldrich CE, Saputelli J, Litwin S, Condreay LD, Seeger C, Mason WS.
    J Virol; 2000 Dec 15; 74(24):11754-63. PubMed ID: 11090175
    [Abstract] [Full Text] [Related]

  • 13. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
    Cullen JM, Smith SL, Davis MG, Dunn SE, Botteron C, Cecchi A, Linsey D, Linzey D, Frick L, Paff MT, Goulding A, Biron K.
    Antimicrob Agents Chemother; 1997 Oct 15; 41(10):2076-82. PubMed ID: 9333028
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication.
    Schinazi RF, Bassit L, Clayton MM, Sun B, Kohler JJ, Obikhod A, Arzumanyan A, Feitelson MA.
    Antimicrob Agents Chemother; 2012 Dec 15; 56(12):6186-91. PubMed ID: 22985879
    [Abstract] [Full Text] [Related]

  • 15. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
    Jacob JR, Korba BE, Cote PJ, Toshkov I, Delaney WE, Gerin JL, Tennant BC.
    Antiviral Res; 2004 Aug 15; 63(2):115-21. PubMed ID: 15302140
    [Abstract] [Full Text] [Related]

  • 16. Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes.
    Lu M, Lohrengel B, Hilken G, Kemper T, Roggendorf M.
    J Virol; 2002 Jan 15; 76(1):58-67. PubMed ID: 11739671
    [Abstract] [Full Text] [Related]

  • 17. Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12.
    Crettaz J, Otano I, Ochoa-Callejero L, Benito A, Paneda A, Aurrekoetxea I, Berraondo P, Rodríguez-Madoz JR, Astudillo A, Kreppel F, Kochanek S, Ruiz J, Menne S, Prieto J, Gonzalez-Aseguinolaza G.
    J Virol; 2009 Mar 15; 83(6):2663-74. PubMed ID: 19116251
    [Abstract] [Full Text] [Related]

  • 18. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.
    Wang J, Gujar SA, Cova L, Michalak TI.
    J Virol; 2007 Jan 15; 81(2):903-16. PubMed ID: 17079319
    [Abstract] [Full Text] [Related]

  • 19. Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B.
    Lim SG, Krastev Z, Ng TM, Mechkov G, Kotzev IA, Chan S, Mondou E, Snow A, Sorbel J, Rousseau F.
    Antimicrob Agents Chemother; 2006 May 15; 50(5):1642-8. PubMed ID: 16641430
    [Abstract] [Full Text] [Related]

  • 20. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
    Le Guerhier F, Pichoud C, Jamard C, Guerret S, Chevallier M, Peyrol S, Hantz O, King I, Trépo C, Cheng YC, Zoulim F.
    Antimicrob Agents Chemother; 2001 Apr 15; 45(4):1065-77. PubMed ID: 11257017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.